Summer 2026 - Research Engineering Internship at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Rising Junior and above undergraduate or M.S. or Ph.D. graduate student in Bioinformatics, Computer Science or related field, no work experience required
Fluency with Linux-based high-performance computing environments, including python, Linux shell scripting, R, ssh and git
Strong programming background in Python
Knowledge of and experience applying generative AI and LLM technologies to practical problems; e.g. development of AI-powered chatbots a plus
Familiarity with AI agent frameworks (e.g., LangGraph, CrewAI, AgentCore, AWS Bedrock Agents) and MCP servers a plus
Web development experience and experience working with AWS technologies such as EC2, Beanstalk, S3, and Bedrock a plus
Strong problem-solving and collaboration skills, and rigorous and creative thinking
Excellent written and oral communication skills, including an ability to explain complex ideas to computational scientists, experimentalists, and clinicians
The ability to collaborate

Responsibilities

Focus on applying generative AI, large language models (LLMs), and agentic frameworks to solve practical problems in translational research and drug development at BMS
Build intelligent tools and systems that enhance data accessibility, streamline exploratory analysis, and facilitate integration and quality across core R&D datasets
Work in close collaboration with Enterprise IT and assist in expanding the team’s capabilities
Gain an understanding of the drug development process through interactions with project teams and opportunities to network with individuals from multiple disciplines in BMS

Skills

Generative AI

LLMs

AI Agents

Computational Data Processing

Data Integration

Research Analytics

Translational Research

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free